Makale
Tam Makale
Uluslararası
2018
Assessment of Quality of Life of Patients with Chronic Hepatitis B and C Treated with Pegylated Interferon-alpha
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
Cilt 24 · Sayı 2 · ss. 25–42 · 01.08.2018
Özet
Objectives: It was aimed to evaluate health-related quality of life of patients with non-cirrhotic chronic hepatitis B (CHB) and chronic hepatitis C (CHC) during interferon therapy with the standard short form-36 (SF-36).
Anahtar kelimeler
IMPACT
Health
chronic hepatitis B
chronic hepatitis C
health-related quality of life
interferon therapy
ILLNESS
Sürdürülebilir Kalkınma Amaçları
-
SKA 3: Sağlıklı Bireyler
Atıf için künye
Alay, H., Özden, K., EROL, S., Celik, N., PARLAK, E., & PARLAK, M. (2018). Assessment of Quality of Life of Patients with Chronic Hepatitis B and C Treated with Pegylated Interferon-alpha. VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 24(2), 25–42. https://doi.org/10.4274/vhd.2017.0016
BibTeX
@article{alay2018-225315,
author = {Alay, Handan and Özden, Kemalettin and EROL, Serpil and Celik, Neslihan and PARLAK, Emine and PARLAK, Mehmet},
title = {Assessment of Quality of Life of Patients with Chronic Hepatitis B and C Treated with Pegylated Interferon-alpha},
journal = {VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL},
year = {2018},
volume = {24},
number = {2},
pages = {25--42},
issn = {1307-9441},
doi = {10.4274/vhd.2017.0016},
url = {https://akademik.atauni.edu.tr/yayinlar/225315-assessment-of-quality-of-life-of-patients-with-chronic-hepatitis-b-and-c-treated}
}